About Dr Dionysis Papadatos-Pastos
Dr Dionysis Papadatos-Pastos is a London-based consultant oncologist specialising in the treatment of lung cancer, mesothelioma, thymic tumours, and other thoracic cancers. Recognised as one of the leading private oncologists in London, he combines medical excellence with a compassionate, patient-centred approach to care.
With a strong belief that every patient deserves both advanced science and humanity in equal measure, Dr Papadatos-Pastos supports individuals and their families through every step of the cancer journey — from diagnosis and treatment to long-term wellbeing.
Professional Background and Expertise
Dr Papadatos-Pastos serves as Lead for Lung Cancer at the CRUK UCL Clinical Trials Centre and Co-Chair of The London Clinic Lung Cancer Multidisciplinary Team (MDT).
In these roles, he leads collaborative teams of thoracic surgeons, respiratory physicians, radiologists, and specialist oncology nurses to design personalised treatment plans for each patient.
His clinical expertise includes immunotherapy, targeted therapy, and chemotherapy, with a focus on providing access to the most innovative and effective treatment strategies available in modern oncology.
His work is reflected in patient stories such as Lynda’s journey of living with purpose after cancer, or Fighting the odds – Sharon’s journey to beat cancer, highlighting the importance of integrated, compassionate cancer care.
Education and Training
Dr Papadatos-Pastos graduated in Medicine with distinction from the University of Athens, later earning a PhD in Medical Oncology (First Class Honours).
He completed advanced clinical training at leading UK cancer institutions, including The Royal Marsden Hospital, where he held a Clinical Fellowship at the world-renowned Drug Development Unit.
During this period, he contributed to the early development of new cancer drugs, pioneering research in targeted therapies and immunotherapy combinations.
He also holds a Diploma in Medical Oncology from the Institute of Cancer Research, University of London.
Research and Clinical Trials
As an active clinical researcher, Dr Papadatos-Pastos has served as Principal Investigator on numerous academic and commercial clinical trials. His research focuses on non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), and mesothelioma, aiming to expand access to new treatments and improve outcomes for patients worldwide.
His work has been published in international peer-reviewed journals, and he regularly presents at major oncology conferences in the UK and abroad, sharing advancements in thoracic cancer treatment.
Every patient deserves care that combines science, empathy, and honesty. My mission is to help each person feel supported, informed, and hopeful throughout their cancer journey.
Meet me at trusted clinics across London.
Access expert oncology advice from anywhere in the world.
Contact Dr Papadatos - Pastos
If you or a loved one would like to discuss diagnosis, treatment options, or ongoing care, you can schedule a private consultation in London or remotely via secure video call.
Guide for New Patients
Practical information for patients and families preparing for their first consultation.
Faq
Answers to Common Questions
Here you can find answers to some of the most common questions about Dr. Papadatos-Pastos and his approach to cancer care. These responses are designed to offer clarity and reassurance for patients and their families, helping you feel supported and informed at every step of your treatment journey.
Dr. Papadatos-Pastos specialises in thoracic oncology, focusing on lung cancer, mesothelioma, thymic tumours, and other complex chest cancers. His work combines cutting-edge treatments such as immunotherapy and targeted therapy with compassionate, patient-centred care.
He consults privately at several leading London hospitals and clinics, offering both in-person and remote consultations to ensure accessibility for patients across the UK and abroad.
He believes in personalised medicine — every treatment plan is tailored to each patient’s condition, lifestyle, and emotional needs. His approach emphasises collaboration, clear communication, and holistic support throughout the cancer journey.
Yes. He is an active clinical researcher and Lead for Lung Cancer at the CRUK UCL Clinical Trials Centre. He participates in international research focused on new cancer therapies, helping bring innovative treatments to patients sooner.
Appointments can be booked directly via his website contact form or through the clinic reception team. Both self-referrals and referrals from healthcare professionals are welcome.